Skip to content
lifestyle.digitaladblog.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Diakonos Oncology Corp.
Diakonos Oncology DOC1021 Clinical Data in Glioblastoma Selected for Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting
November 3, 2026
Diakonos Oncology Announces First Patients Dosed in Phase 1/2 DOC-RM Study of DOC1021 in Refractory Melanoma
July 30, 2026